Presentation is loading. Please wait.

Presentation is loading. Please wait.

Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) id:

Similar presentations


Presentation on theme: "Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) id:"— Presentation transcript:

1 Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

2 Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Global Orphan Drug market is estimated at $145.89 million in 2016 and is expected to reach $265.63 million by 2022 growing at a CAGR of 10.5% from 2016 to 2022. Rising focus of big pharmaceutical companies on orphan drug improvement, increasing occurrence of rare diseases, government incentives for orphan medicine are some factors favouring the market growth. Browse the report: http://www.orbisresearch.com/reports/index/orphan-drug-global-market-outlook-2016-2022 However, some factors such as high initial investment that leads to higher per patient treatment cost, reimbursement uncertainties and high cost of drug development are hindering the market. North America registered significant growth for the market during the forecast period due to rising healthcare spending, constructive government initiatives, growing occurrence of chronic diseases and small timeline required for orphan drug development. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

3 Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/255591 Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, increasing prevalence of cardiovascular diseases and diabetes in countries such as India and China. Some of the key players in the market include Abbott Laboratories, AbbVie Inc., Alexion Pharmaceuticals, Amgen, Inc., Bayer Healthcare, Boehringer Ingelheim GmbH, Bristol Myers Squibb, Celgene Corporation, F. Hoffmann-La Roche AG, Genentech, Janssen Biotech, Inc., Johnson & Johnson, Merck & Co., Inc., Novartis, Pfizer Inc., Roche Holding AG, Sanofi Aventis and Vertex Pharmaceuticals. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

4 About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022


Download ppt "Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) id:"

Similar presentations


Ads by Google